Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $350.17 | 42 | 91.7% |
| Education | $31.50 | 1 | 8.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $273.94 | 36 | $0 (2024) |
| Allergan, Inc. | $68.89 | 4 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $23.22 | 2 | $0 (2021) |
| Alkermes, Inc. | $15.62 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.29 | 1 | ABBVIE INC. ($16.29) |
| 2022 | $23.36 | 2 | ABBVIE INC. ($23.36) |
| 2021 | $245.86 | 34 | AbbVie Inc. ($234.29) |
| 2020 | $12.04 | 1 | Allergan, Inc. ($12.04) |
| 2019 | $11.51 | 1 | Allergan Inc. ($11.51) |
| 2018 | $58.77 | 3 | Allergan Inc. ($31.50) |
| 2017 | $13.84 | 1 | Allergan Inc. ($13.84) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: CNS | ||||||
| 06/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 36 | 79 | $6,715 | $3,121 |
| 2022 | 1 | 48 | 93 | $7,905 | $4,255 |
| 2021 | 1 | 47 | 99 | $8,415 | $4,841 |
| 2020 | 1 | 73 | 148 | $12,580 | $5,489 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 79 | $6,715 | $3,121 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 93 | $7,905 | $4,255 | 53.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 99 | $8,415 | $4,841 | 57.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 73 | 148 | $12,580 | $5,489 | 43.6% |
About Dr. Joel Last, MD
Dr. Joel Last, MD is a Psychiatry healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750325031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Last, MD has received a total of $381.67 in payments from pharmaceutical and medical device companies, with $16.29 received in 2024. These payments were reported across 43 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($350.17).
As a Medicare-enrolled provider, Last has provided services to 204 Medicare beneficiaries, totaling 419 services with total Medicare billing of $17,706. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Latrobe, PA
- Active Since 06/16/2006
- Last Updated 02/26/2009
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1750325031
Products in Payments
- VRAYLAR (Drug) $342.83
- LATUDA (Drug) $23.22
- Vivitrol 380 mg (Drug) $15.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.